Back to Dashboard
ENOV · Healthcare

ENOVIS CORPORATION

USA Healthcare Filing: 2025-12-31
Smart-money confidence · 1 of 3 sources firing
Bearish — money moving out

No standout activity across the feeds we track.

Hedge funds
26
Congress
0
Insiders
50
Cross-source blend of hedge-fund breadth, Congress trades, and insider Form 4s.  ·  how the score works
Limited info. ENOVIS CORPORATION is not currently in our model portfolio, but 5 tracked investors hold it. We're showing what we know from their latest 13F filings.
Market cap
$1.6B
Industry
Medical Devices
Exchange
NYSE
Enovis Corporation, a medical technology company, focuses on developing clinically differentiated solutions in the United States and internationally. It operates through two segments: Prevention and Recovery, and Reconstructive segments. The Prevention and Recovery segment offers rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, electrical stimulators for pain management, and physical therapy products which are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists,…
5
Investors
0
New positions
3
Increasing
2
Decreasing
0
Unchanged
Price History
Loading price data...
Return: High: Low:
Who's Holding This Stock
Position sizes and recent activity from tracked institutional investors
Millennium Management (Englander)
Trust weight: 1.0×
Increased +24%
% of portfolio
0.0%
Position change
+24%
0.0% of Millennium Management's portfolio
D.E. Shaw & Co
Trust weight: 1.0×
Increased +1207%
% of portfolio
0.0%
Position change
+1207%
0.0% of D.E. Shaw & Co's portfolio
AQR Capital Management
Trust weight: 1.0×
Increased +37%
% of portfolio
0.0%
Position change
+37%
0.0% of AQR Capital Management's portfolio
Southeastern Asset Mgmt (Longleaf)
Trust weight: 1.2×
Decreased −19%
% of portfolio
0.1%
Position change
−19%
0.1% of Southeastern Asset Mgmt's portfolio
Citadel Advisors
Trust weight: 1.0×
Decreased −54%
% of portfolio
0.0%
Position change
−54%
0.0% of Citadel Advisors's portfolio
Portfolio Allocation
How much of each investor's portfolio is allocated to ENOVIS CORPORATION
⚠ Disclaimer: This page is for informational purposes only. Holdings data from SEC EDGAR 13F filings, delayed up to 135 days. Not a recommendation to buy or sell ENOVIS CORPORATION or any security.

Get the Weekly Update

Every Sunday, we'll send you what Buffett, Dalio, Ackman and 47 other legendary investors are buying — free, straight from their SEC filings.
Free forever · No spam · Unsubscribe anytime
© 2026 Bogen Capital  ·  Not financial advice  ·  Data delayed up to 135 days Methodology  ·  Contact  ·  API